|
Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA
|
3
|
339
|
January 9, 2020
|
|
Newron Pharmaceuticals Completes Enrollment for Pioneering Schizophrenia Drug Trial
|
2
|
272
|
January 10, 2024
|
|
Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal
|
0
|
192
|
December 29, 2023
|
|
Newron Presents Encouraging Detailed Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia
|
10
|
1008
|
March 26, 2017
|
|
Newron announces encouraging preliminary results of its Phase IIa study with Evenamide in patients with schizophrenia
|
14
|
1390
|
January 4, 2017
|